Processing of microRNA primary transcripts requires heme in mammalian cells

• Published in: Proceedings of the National Academy of Sciences - PNAS 2014-02, Vol.111 (5), p.1861-1866
• Main Authors: Weitz, Sara H., Gong, Ming, Barr, Ian, Weiss, Shimon, Guo, Feng
• Format: Article
• Language: English
• Subjects: Animals; Anura; Asteroidea; Base Sequence; Biochemistry; Biological Sciences; Biosynthesis; Cell lines; E coli; Escherichia coli; Fluorescence; Gene expression; Genes, Reporter; HeLa Cells; Heme - biosynthesis; Heme - metabolism; Humans; Iron; Journalism; Mammals; Marine; Messenger RNA; MicroRNA; MicroRNAs; MicroRNAs - genetics; MicroRNAs - metabolism; Molecular Sequence Data; Mutant Proteins - metabolism; Nucleotide Motifs - genetics; Physiology; Plasmids; Protein Binding; Proteins - metabolism; Ribonuclease III - metabolism; RNA; RNA Processing, Post-Transcriptional - genetics; RNA, Messenger; RNA-Binding Proteins; Transfection
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.1309915111

DiGeorge syndrome critical region gene 8 (DGCR8) is the RNA-binding partner protein of the nuclease Drosha. DGCR8 and Drosha recognize and cleave primary transcripts of microRNAs (pri-miRNAs) in the maturation of canonical microRNAs (miRNAs) in animals. We previously reported that human, frog, and starfish DGCR8 bind heme when expressed in Escherichia coli and that Fe (III) heme activates apoDGCR8 in reconstituted pri-miRNA processing assays. However, the physiological relevance of heme in miRNA maturation has not been clear. Here, we present a live-cell pri-miRNA processing assay that produces robust signals and faithfully indicates DGCR8 and Drosha activities. We demonstrate that all known heme-binding–deficient DGCR8 mutants are defective in pri-miRNA processing in HeLa cells. DGCR8 contains a previously uncharacterized heme-binding motif, "IPCL," that is also required for its activity. Heme availability and biosynthesis in HeLa cells positively affect pri-miRNA processing and production of mature miRNA. These results establish an essential function for heme in pri-miRNA processing in mammalian cells. Our study suggests that abnormal heme biosynthesis and degradation may contribute to diseases via miRNA-mediated gene regulation networks.